Allarity Therapeutics announced a strategic capital allocation in conjunction with its newly formed SPAC, Allarity Acquisition Corp., which has publicly filed a registration statement. This move signals the SPAC's intent to pursue a merger or acquisition, impacting future investment opportunities.
Allarity Therapeutics SPAC Files Registration Statement
Allarity TherapeuticsSPACRegistration StatementCapital AllocationBiotechnology
